Youre transforming your entire metabolic ecosystem
It originates from the preproglucagon precursor, which undergoes enzymatic processing within intestinal L-cells, ultimately giving rise to GLP-1(1-37) and GLP-1(7-36) amide or GLP-1(7-37) peptide variants
The information provided on this blog is for general informational purposes only
rotate: Lamiophlomis rotate SM: Shanzhiside methylester MAPK: p38 mitogen-activated protein kinase DPN: Diabetic peripheral neuropathy MCU: Mitochondrial calcium uniporter UCP3: Uncoupling protein 3 DRP1: Dynamin-related protein 1 STZ: Streptozotocin ERK: Extracellular signal-regulated kinase MMP-2: Matrix metalloproteinases-2 MMP-9: Matrix metalloproteinases-9 NLRP3: NOD-like receptor protein 3 AGEs: Advanced glycation end products CSA: Cross-sectional area CM: Chronic migraine TNC: Trigeminal nucleus caudalis CGRP: Calcitonin gene-related peptide ICP: Intracranial pressure CSF: Cerebrospinal fluid IIH: Idiopathic intracranial hypertension References Zheng Z, Zong Y, Ma Y, Tian Y, Pang Y, Zhang C, Gao J (2024) Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Understanding GLP-1 Medications GLP-1 medications mimic the natural hormone GLP-1, which is produced in the gut in response to eating
Feeling unusually cold is not a primary listed side effect in clinical trials, but many patients report it during active weight loss on GLP-1 therapy